Dopamine D1 and D2 receptor subtypes functional regulation in corpus striatum of unilateral rotenone lesioned Parkinson's rat model

Effect of serotonin, dopamine and norepinephrine

Jes Paul, M. S. Nandhu, Korah P. Kuruvilla, C. S. Paulose

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Parkinson's disease (PD) is due to widespread degeneration in the central and peripheral nervous systems. The hallmark pathology remains in the dopaminergic striatal insufficiency and degeneration of dopaminergic neurons in the substantia nigra. Objectives: The present study analysed the effect of serotonin (5-HT), dopamine, and norepinephrine as treatment on rotenone induced hemi-Parkinson's disease in rats and its role in the regulation of dopamine receptor subtypes in the corpus striatum of the experimental rats. Methods: Unilateral stereotaxic single-dose infusions of rotenone were administered to the substantia nigra of adult male Wistar rats. Neurotransmitters serotonin (5-HT), dopamine, and norepinephrine treatments were given to rotenone induced hemi-Parkinson's rats. Dopamine receptor and its subtypes (D1 and D2) binding assay were carried out. Gene expression studies of dopamine D1 and D2 were carried out using real-time PCR. Results: Scatchard analysis of dopamine and dopamine D2 receptor showed a significant increase (P<0.001) and dopamine D1 receptor showed a significant decrease (P<0.001) in the Bmax in corpus striatum of the PD rats compared to control. These altered parameters were reversed to near control in the serotonin-and norepinephrine-treated PD rats and no change was observed in dopamine-treated PD rats. Real-time PCR results confirmed the receptor data. Conclusion: Our results showed that serotonin and norepinephrine functionally reversed in dopamine receptors in rotenone-induced hemi-Parkinson's rat. This has clinical significance in the therapeutic management of PD.

Original languageEnglish (US)
Pages (from-to)918-924
Number of pages7
JournalNeurological Research
Volume32
Issue number9
DOIs
StatePublished - Nov 1 2010

Fingerprint

Corpus Striatum
Rotenone
Dopamine D1 Receptors
Dopamine D2 Receptors
Dopamine
Serotonin
Norepinephrine
Parkinson Disease
Dopamine Receptors
Substantia Nigra
Real-Time Polymerase Chain Reaction
Dopaminergic Neurons
Peripheral Nervous System
Neurotransmitter Agents
Wistar Rats
Central Nervous System
Pathology
Gene Expression

All Science Journal Classification (ASJC) codes

  • Medicine(all)
  • Neurology
  • Clinical Neurology

Cite this

@article{dde6a74168a644b6939b15b52a6ef2ff,
title = "Dopamine D1 and D2 receptor subtypes functional regulation in corpus striatum of unilateral rotenone lesioned Parkinson's rat model: Effect of serotonin, dopamine and norepinephrine",
abstract = "Parkinson's disease (PD) is due to widespread degeneration in the central and peripheral nervous systems. The hallmark pathology remains in the dopaminergic striatal insufficiency and degeneration of dopaminergic neurons in the substantia nigra. Objectives: The present study analysed the effect of serotonin (5-HT), dopamine, and norepinephrine as treatment on rotenone induced hemi-Parkinson's disease in rats and its role in the regulation of dopamine receptor subtypes in the corpus striatum of the experimental rats. Methods: Unilateral stereotaxic single-dose infusions of rotenone were administered to the substantia nigra of adult male Wistar rats. Neurotransmitters serotonin (5-HT), dopamine, and norepinephrine treatments were given to rotenone induced hemi-Parkinson's rats. Dopamine receptor and its subtypes (D1 and D2) binding assay were carried out. Gene expression studies of dopamine D1 and D2 were carried out using real-time PCR. Results: Scatchard analysis of dopamine and dopamine D2 receptor showed a significant increase (P<0.001) and dopamine D1 receptor showed a significant decrease (P<0.001) in the Bmax in corpus striatum of the PD rats compared to control. These altered parameters were reversed to near control in the serotonin-and norepinephrine-treated PD rats and no change was observed in dopamine-treated PD rats. Real-time PCR results confirmed the receptor data. Conclusion: Our results showed that serotonin and norepinephrine functionally reversed in dopamine receptors in rotenone-induced hemi-Parkinson's rat. This has clinical significance in the therapeutic management of PD.",
author = "Jes Paul and Nandhu, {M. S.} and Kuruvilla, {Korah P.} and Paulose, {C. S.}",
year = "2010",
month = "11",
day = "1",
doi = "10.1179/016164110X12700393823417",
language = "English (US)",
volume = "32",
pages = "918--924",
journal = "Neurological Research",
issn = "0161-6412",
publisher = "Maney Publishing",
number = "9",

}

TY - JOUR

T1 - Dopamine D1 and D2 receptor subtypes functional regulation in corpus striatum of unilateral rotenone lesioned Parkinson's rat model

T2 - Effect of serotonin, dopamine and norepinephrine

AU - Paul, Jes

AU - Nandhu, M. S.

AU - Kuruvilla, Korah P.

AU - Paulose, C. S.

PY - 2010/11/1

Y1 - 2010/11/1

N2 - Parkinson's disease (PD) is due to widespread degeneration in the central and peripheral nervous systems. The hallmark pathology remains in the dopaminergic striatal insufficiency and degeneration of dopaminergic neurons in the substantia nigra. Objectives: The present study analysed the effect of serotonin (5-HT), dopamine, and norepinephrine as treatment on rotenone induced hemi-Parkinson's disease in rats and its role in the regulation of dopamine receptor subtypes in the corpus striatum of the experimental rats. Methods: Unilateral stereotaxic single-dose infusions of rotenone were administered to the substantia nigra of adult male Wistar rats. Neurotransmitters serotonin (5-HT), dopamine, and norepinephrine treatments were given to rotenone induced hemi-Parkinson's rats. Dopamine receptor and its subtypes (D1 and D2) binding assay were carried out. Gene expression studies of dopamine D1 and D2 were carried out using real-time PCR. Results: Scatchard analysis of dopamine and dopamine D2 receptor showed a significant increase (P<0.001) and dopamine D1 receptor showed a significant decrease (P<0.001) in the Bmax in corpus striatum of the PD rats compared to control. These altered parameters were reversed to near control in the serotonin-and norepinephrine-treated PD rats and no change was observed in dopamine-treated PD rats. Real-time PCR results confirmed the receptor data. Conclusion: Our results showed that serotonin and norepinephrine functionally reversed in dopamine receptors in rotenone-induced hemi-Parkinson's rat. This has clinical significance in the therapeutic management of PD.

AB - Parkinson's disease (PD) is due to widespread degeneration in the central and peripheral nervous systems. The hallmark pathology remains in the dopaminergic striatal insufficiency and degeneration of dopaminergic neurons in the substantia nigra. Objectives: The present study analysed the effect of serotonin (5-HT), dopamine, and norepinephrine as treatment on rotenone induced hemi-Parkinson's disease in rats and its role in the regulation of dopamine receptor subtypes in the corpus striatum of the experimental rats. Methods: Unilateral stereotaxic single-dose infusions of rotenone were administered to the substantia nigra of adult male Wistar rats. Neurotransmitters serotonin (5-HT), dopamine, and norepinephrine treatments were given to rotenone induced hemi-Parkinson's rats. Dopamine receptor and its subtypes (D1 and D2) binding assay were carried out. Gene expression studies of dopamine D1 and D2 were carried out using real-time PCR. Results: Scatchard analysis of dopamine and dopamine D2 receptor showed a significant increase (P<0.001) and dopamine D1 receptor showed a significant decrease (P<0.001) in the Bmax in corpus striatum of the PD rats compared to control. These altered parameters were reversed to near control in the serotonin-and norepinephrine-treated PD rats and no change was observed in dopamine-treated PD rats. Real-time PCR results confirmed the receptor data. Conclusion: Our results showed that serotonin and norepinephrine functionally reversed in dopamine receptors in rotenone-induced hemi-Parkinson's rat. This has clinical significance in the therapeutic management of PD.

UR - http://www.scopus.com/inward/record.url?scp=77957574507&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77957574507&partnerID=8YFLogxK

U2 - 10.1179/016164110X12700393823417

DO - 10.1179/016164110X12700393823417

M3 - Article

VL - 32

SP - 918

EP - 924

JO - Neurological Research

JF - Neurological Research

SN - 0161-6412

IS - 9

ER -